← Open Payments lookup

KEEFE LOBB: Open Payments

NPI 1972890523 · MIDLOTHIAN, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,552 in 91 payments from 26 companies in 2025. Trend: 2023 $1,283 · 2024 $1,068 · 2025 $1,552

Food & beverage: $1,552
CompanyPaymentsAmount
ABBVIE INC.18$252
PFIZER INC.13$204
Novo Nordisk Inc10$159
Lilly USA, LLC9$150
AstraZeneca Pharmaceuticals LP5$139
Salix Pharmaceuticals, a division of Bausch Health US, LLC5$86
Boehringer Ingelheim Pharmaceuticals, Inc.3$55
Teva Pharmaceuticals USA, Inc.3$49
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)2$45
Abbott Laboratories2$40

Products named: QULIPTA, MOUNJARO, NURTEC ODT, FARXIGA, UBRELVY, XIFAXAN, JARDIANCE, Ozempic.

Industry payments across VA — which companies pay providers there.